Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dendritic cell vaccines in melanoma: from promise to proof?

Critical reviews in oncology/hematology - 1 May 2008

Lesterhuis W J, Aarntzen E H J G, De Vries I J M, Schuurhuis D H, Figdor C G, Adema G J, Punt C J A

Abstract excerpt

Dendritic cells (DC) are the directors of the immune system, capable of inducing tumour antigen-specific T- and B-cell responses. As such, they are currently applied in clinical studies in cancer patients. Early small clinical trials showed promising results, with frequent induction of anti-cancer immune reactivity and clinical responses. In recent years, additional trials have been carried out in melanoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigen Presentation
Share to Cancer Vaccines
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Combined Modality Therapy

Share to Dendritic Cells

Share to Immune Tolerance

Share to Immunotherapy, Adoptive

Share to Research Design

Source

Identifiers

PMID: 18262431
DOI: 10.1016/j.critrevonc.2007.12.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dendritic cell vaccines in melanoma: from promise to proof?PMID 18262431Read ↗

Review: dendritic cell immunotherapy for melanoma.Semantic proximity Read ↗

Dendritic cells in cancer immunotherapySemantic proximity Read ↗

Dendritic Cells and Their Role in Immunotherapy.Semantic proximity Read ↗

Cellular Immunotherapy with Dendritic Cells in Cancer: Current StatusSemantic proximity Read ↗

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injectionSemantic proximity Read ↗

New approaches to the development of adenoviral dendritic cell vaccines in melanoma.Semantic proximity Read ↗

Phenotypical and functional characterization of clinical-grade dendritic cells.Semantic proximity Read ↗

Refining Dendritic Cell-Based Cancer Vaccines: Subset Targeting, Translational Barriers, and Emerging StrategiesSemantic proximity Read ↗

Antigen presentation requirements for effective cDC1-based cancer immunotherapySemantic proximity Read ↗

Overview of melanoma vaccines and promising approaches.Semantic proximity Read ↗

Dendritic Cells: Master Regulators of the Immune ResponseSemantic proximity Read ↗

Development of Cell Technologies Based on Dendritic Cells for Immunotherapy of Oncological DiseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.